Related references
Note: Only part of the references are listed.The Prevalence and Determinants of Cognitive Deficits and Traditional Diabetic Complications in the Severely Obese
Brian C. Callaghan et al.
DIABETES CARE (2020)
Central Obesity is Associated With Neuropathy in the Severely Obese
Brian C. Callaghan et al.
MAYO CLINIC PROCEEDINGS (2020)
Glycosylated sphingolipids and progression to kidney dysfunction in type 1 diabetes
Maria F. Lopes-Virella et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Quantifying 1-deoxydihydroceramides and 1-deoxyceramides in mouse nervous system tissue
Nicholas U. Schwartz et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2019)
Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy
Marin L. Gantner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Randomized trial of l-serine in patients with hereditary sensory and autonomic neuropathy type 1
Vera Fridman et al.
NEUROLOGY (2019)
Deoxysphingolipid precursors indicate abnormal sphingolipid metabolism in individuals with primary and secondary disturbances of serine availability
C. R. Ferreira et al.
MOLECULAR GENETICS AND METABOLISM (2018)
Hereditary sensory neuropathy type 1-associated deoxysphingolipids cause neurotoxicity, acute calcium handling abnormalities and mitochondrial updates dysfunction in vitro
Emma R. Wilson et al.
NEUROBIOLOGY OF DISEASE (2018)
L-serine supplementation lowers diabetes incidence and improves blood glucose homeostasis in NOD mice
Laurits J. Holm et al.
PLOS ONE (2018)
Increased Plasma Levels of Select Deoxy-ceramide and Ceramide Species are Associated with Increased Odds of Diabetic Neuropathy in Type 1 Diabetes: A Pilot Study
Samar M. Hammad et al.
NEUROMOLECULAR MEDICINE (2017)
Metabolic profiling of type 1 diabetes mellitus in children and adolescents: a case-control study
Liene Bervoets et al.
DIABETOLOGY & METABOLIC SYNDROME (2017)
Metabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status
Brian C. Callaghan et al.
DIABETES CARE (2016)
1-Deoxysphingolipid-induced neurotoxicity involves N-methyl-D-aspartate receptor signaling
Tanja Guntert et al.
NEUROPHARMACOLOGY (2016)
Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population
Brian C. Callaghan et al.
JAMA NEUROLOGY (2016)
Three-minute method for amino acid analysis by UHPLC and high-resolution quadrupole orbitrap mass spectrometry
Travis Nemkov et al.
AMINO ACIDS (2015)
Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
M. F. Dohrn et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Neurotoxic 1-deoxysphingolipids and paclitaxel-induced peripheral neuropathy
Rita Kramer et al.
FASEB JOURNAL (2015)
An Assay of Selected Serum Amino Acids in Patients with Type 2 Diabetes Mellitus
Petra Drabkova et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2015)
Plasma Free Amino Acid Profiles Predict Four-Year Risk of Developing Diabetes, Metabolic Syndrome, Dyslipidemia, and Hypertension in Japanese Population
Minoru Yamakado et al.
SCIENTIFIC REPORTS (2015)
Lowering Plasma 1-Deoxysphingolipids Improves Neuropathy in Diabetic Rats
Alaa Othman et al.
DIABETES (2015)
Plasma 1-deoxysphingolipids are predictive biomarkers for type 2 diabetes mellitus
Alaa Othman et al.
BMJ OPEN DIABETES RESEARCH & CARE (2015)
Deoxysphingolipids, Novel Biomarkers for Type 2 Diabetes, Are Cytotoxic for Insulin-Producing Cells
Richard A. Zuellig et al.
DIABETES (2014)
Altered sphingoid base profiles in type 1 compared to type 2 diabetes
Nancy Wei et al.
LIPIDS IN HEALTH AND DISEASE (2014)
Metabolomic Profiling of Fatty Acid and Amino Acid Metabolism in Youth With Obesity and Type 2 Diabetes Evidence for enhanced mitochondrial oxidation
Stephanie J. Mihalik et al.
DIABETES CARE (2012)
Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome?
A. Othman et al.
DIABETOLOGIA (2012)
Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1
Kevin Garofalo et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
Solomon Tesfaye et al.
DIABETES CARE (2010)
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Fe-deration of Neurological Societies and the Peripheral Nerve Society
G. Lauria et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Hereditary Sensory Neuropathy Type 1 Is Caused by the Accumulation of Two Neurotoxic Sphingolipids
Anke Penno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study
Giuseppe Lauria et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2010)
Deoxysphingoid bases as plasma markers in Diabetes mellitus
Mariana Bertea et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Ceramide Synthase Inhibition by Fumonisin B1 Causes Accumulation of 1-Deoxysphinganine A NOVEL CATEGORY OF BIOACTIVE 1-DEOXYSPHINGOID BASES AND 1-DEOXYDIHYDROCERAMIDES BIOSYNTHESIZED BY MAMMALIAN CELL LINES AND ANIMALS
Nicholas C. Zitomer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Clinical, pathological and genetic characterization of hereditary sensory and autonomic neuropathy type 1 (HSAN I)
H Houlden et al.
BRAIN (2006)
Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients
GL Pittenger et al.
DIABETES CARE (2004)
Share Paper
